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Brief Communicationspossible complications. However, incomplete resection of the he-
matoma resulted in uncontrollable bleeding from the subcapsular
lesion or recurrence of hematoma within several years in some
publications.2,7 Complete extirpation, including the capsule, would
be desired for cure.
In our patient acute massive hemoptysis was treated with
emergency tracheal intubation, balloon occlusion of the bleeding
bronchus, and bronchial artery embolization. In the literature nei-
ther massive hemoptysis nor emergency management for chronic
expanding hematoma of the thorax has been reported. Because the
bleeding spread to the contralateral lung, the operation was inten-
tionally delayed until the remaining lung function recovered.
Thereafter, the patient successfully underwent a pneumonectomy
with extirpation of the hematoma. Division of the hilum first and
sequential distal dissection of the lung and hematoma through a
median sternotomy might have worked well for bleeding control.1840 The Journal of Thoracic and Cardiovascular Surgery ● JunReferences
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in the chest. Jpn J Thorac Surg. 2000;53:768-73.Thyroid metastasis after resection of atypical bronchial carcinoid
Pier Luigi Filosso, MD,a Anna Arslanian, MD,a Nicola Palestini, MD,b Alessandra Farnetti, MD,b Mauro Papotti, MD,c
Massimo Bongiovanni, MD,c Roberto Giobbe, MD,a and Enrico Ruffini, MD,a Torino, ItalyBronchial carcinoids (BCs) are rare and constitute lessthan 2% of pulmonary tumors.1 They are characterizedby slow, mainly endobronchial growth, with infrequentregional lymph node involvement or distant metastases.2
Atypical carcinoids are part of the spectrum of neuroendocrine
bronchopulmonary tumors, according to the 1999 World Health
Organization–International Association for the Study of Lung
Cancer (WHO-IASLC) Lung Tumor classification.3 They present
2 low-grade (typical and atypical carcinoids) and 2 high-grade
malignant varieties (large cell neuroendocrine carcinoma and
small cell lung carcinoma), the latter characterized by a high
tendency toward mediastinal and distant metastatic spread.
Among low-grade malignant tumors, atypical carcinoids show
a more aggressive biologic behavior than typical carcinoids4:
mediastinal lymph node metastases occur at presentation in about
15% of cases. Distant metastases are generally in the liver and in
the bone.
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doi:10.1016/j.jtcvs.2003.03.005We present a case of a woman in whom thyroid metastasis
occurred 30 months after the resection of an atypical BC.
Clinical Summary
A 53-year-old white woman was referred to us in June 1999
because of the presence of a large pulmonary mass (7  3 cm in
size) in the right lower lobe. The lesion had been detected with
chest radiography performed in July 1998, and it was 5  2 cm in
size, but at that time, the patient refused the intervention. She
eventually agreed to be operated on because of the progression of
the lesion and the associated cough and dyspnea. A preoperative
transthoracic fine-needle aspiration biopsy was performed, and
neoplastic cells with neuroendocrine features were observed.
111In-DTPA-Pentetreotide scintigraphy (Octreoscan) was per-
formed for a correct preoperative assessment, resulting in an
elective uptake in correspondence of the pulmonary lesion with no
other abnormal uptakes. Chromogranin A and neuron-specific
enolase serum levels were performed and increased: 197 ng/mL
(normal values, 20-100 ng/mL) and 62 ng/mL (normal values,
12.5 ng/mL), respectively.
The patient underwent a right pneumonectomy with systemic
lymphadenectomy: a more conservative intervention was not pos-
sible because of the tumor size. A residual tumor was left on the
inferior pulmonary vein stump.
Grossly, an 8-cm mass with poorly demarcated borders infil-
trating the mediastinal pleura and the adipose mediastinal tissue
was found. The cut surface was tan-yellow, and a brown lymph
node was adherent and directly infiltrated by the tumor.
Microscopically, the tumor was not capsulated, and it had a
uniform organoid growth pattern composed of nests and sheets of
cuboidal and eosinophilic cells. Rosette-like structures were also
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Brief Communicationsevident. The nuclei had either finely granular or coarse chromatin,
and nucleoli were occasionally present (Figure 1, A). The inferior
pulmonary vein was infiltrated by neoplastic cells. Limited foci of
necrosis were evident, and the mitotic count was 3 per 10 high-
power fields. One peribronchial lymph node and the visceral pleura
were directly infiltrated by the tumor.
Immunohistochemically, the cells were strongly positive for
chromogranin A (clone LK2H10; Dako, Glostrup, Denmark) and
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Brief CommunicationsA strict follow-up was planned with thoracic and upper abdom-
inal computed tomographic scanning, Octreoscan, serum chromo-
granin A, and neuron-specific enolase dosages.
In December 2001, Octreoscan showed an uptake in the right
thyroid lobe (Figure 2); an ultrasonographic evaluation demon-
strated the presence of a 2  1–cm nodule. A fine-needle aspira-
tion biopsy was performed: the highly cellular smears contained
medium-sized polygonal and eosinophilic neoplastic cells with
finely granular chromatin and faint nucleoli. These cells were
unreactive for thyroglobulin and calcitonin and positive for chro-
mogranin A. Diagnosis of thyroid metastasis of neurendocrine
carcinoma of the lung was thus made.
The patient underwent a radical thyroidectomy and cervical
lymphadenectomy. Grossly, the thyroid weighed 41 g, with mul-
tiple bilateral red-whitish nodules 0.5 to 1.5 cm in size.
Microscopically, these nodules were composed of polygonal
and eosinophilic cells arranged in cords and nests, having the
typical organoid pattern of carcinoid tumors (Figure 1, E-G). Foci
of necrosis were observed. No thyroglobulin immunostaining
(polyclonal; BioGenex, San Ramon, Calif) was seen. The absence
of calcitonin immunoreactivity (polyclonal, Dako) also ruled out
the diagnosis of medullary thyroid carcinoma. Chromogranin A
immunostaining (clone LK2H10, Dako) was strongly positive. The
morphologic features and the similarity with the previously re-
sected pulmonary neuroendocrine lesion confirmed the preopera-
tive diagnosis of metastatic neuroendocrine carcinoma.
The postoperative course was also uneventful.
The patient is alive and well without recurrence 13 months after
the second intervention, and no adjuvant chemotherapy or radio-
therapy was planned; she is now only continuing medical therapy
with Octreotide (Sandostatina LAR 30 mg; Novartis Pharma,
Origgio, Italy), which is well tolerated without important side
effects.
Discussion
BCs have raised important issues for thoracic surgeons, in partic-
ular whether to regard them as benign or malignant tumors. BCs
are a part of the spectrum of the neuroendocrine tumors of the
lung3: the WHO-IASLC classification considers BCs as different
from large cell neuroendocrine carcinoma and small cell lung
carcinoma on the basis of their histologic and biologic features.
BCs are low-grade malignant tumors that can be locally invasive
or spread to mediastinal lymph nodes, but distant metastases are
rare.4 Martini and colleagues2 report that only 10% to 15% of
patients present with regional lymph node metastases at diagnosis.
Surgical intervention represents the treatment of choice, even if
mediastinal nodal metastases are present: BCs are generally unre-
sponsive to preoperative radiation or chemotherapy, and long-term
prognosis is good for both the typical and atypical forms when
treated with radical resection.5
Distant metastases are rare: we experienced liver metastases in
7 patients with radically resected atypical BCs,5,6 in whom carci-
noid syndrome was the first symptom. Octreoscan was effective in
diagnosis, and octreotide therapy allowed us to control symptoms
and to reduce metastases in size in 2 cases.6
We point out the importance of 111In-DTPA-Pentetreotide scin-
tigraphy (Octreoscan) in the early diagnosis of the thyroid metas-
tasis and in general in the follow-up of neurorendocrine lung
1842 The Journal of Thoracic and Cardiovascular Surgery ● Juntumors.7,8 Neuroendocrine tumors in vitro express somatostatin
receptor subtype 2, which can be imaged in vivo by using Oc-
treoscan.
Octreoscan has demonstrated its effectiveness in diagnosis of
the primary tumor but particularly in detecting early recurrences or
distant metastases in asymptomatic patients earlier than with tra-
ditional radiologic procedures.9
A positive Octreoscan result should guide an effective medical
therapy with somatostatin analogs (octreotide and lanreotide).6
Positron emission tomography scanning in the presence of BCs
shows lower uptake than in non–small cell lung cancers; therefore
positron emission tomography scanning is, at present, not indi-
cated for the differential diagnosis of a solitary pulmonary nodule
with neuroendocrine features from a benign process.10
Complete resection with radical mediastinal lymph node dis-
section provides excellent local control and long-term survival in
BCs; the presence of mediastinal metastases does not preclude
surgical intervention.2
Local recurrences are rare and generally associated with an
inadequate (not anatomic) surgical treatment of the primary tumor.
Distant metastases appear to be related to the histologic form of
BCs (atypical carcinoid) more than to the nodal status.2,11 When
possible, surgical intervention remains the treatment of choice for
recurrences because there is no evidence that radiotherapy or
chemotherapy are effective in local control or in long-term sur-
vival.
Our experience provides evidence that the use of somatostatin
analogs (octreotide and lanreotide) is effective in cases of distant
metastases discovered by means of Octreoscan6 in which surgical
intervention is not feasible. Octreotide binds with high affinity to
somatostatin receptor subtype 2, which is expressed in neuroen-
docrine tumoral cells. Octreotide has demonstrated a valid inhib-
itory growth effect on neoplastic cells, and it is well tolerated,
without important side effects. The optimal dose of octreotide is
generally 1500 mg/d subcutaneously, but a recent long-acting form
(Octreotide LAR) appears more simple for patient management
because only one dose every 28 days is necessary.
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301-6.An autopsy case of angiosarcoma arising around a woven Dacron
prosthesis after a Cabrol operation
Masaho Okada, MD,a Eiji Takeuchi, MD,a Yoshio Mori, MD,b Shu Ichihara, MD,b Akihiko Usui, MD,c and
Yuichi Ueda, MD,c Nagoya, JapanClinical Summary
A 50-year-old man who was given a diagnosis of Marfan syn-
drome was hospitalized because of a right visual field defect. He
had undergone a Cabrol operation for annuloaortic ectasia and
aortic valve regurgitation 17 years earlier. His ascending aorta and
aortic root were replaced with a woven Dacron graft (DeBakey
Vasculour; C.R. Bard, Inc, Murray Hill, NJ) and a mechanical
valve (Bjo¨rk-Shiley monostrut heart valve, 25 mm; Shiley, Inc,
Irvine, Calif). He underwent mitral valve replacement with a
mechanical valve for mitral valve insufficiency caused by acute
endocarditis 5 years earlier. He was hospitalized because of right-
side hemiparesis but fell into a semicoma thereafter. Computed
tomography (CT) revealed a left occipital brain tumorous shadow.
A tumorectomy of the left occipital lobe was performed, but the
patient died as a result of an expanding brain hemorrhage 2 weeks
later. The brain tumor was diagnosed as metastatic angiosarcoma.
Autopsy Findings
The aortic root had a wrap inclusion of the aneurysmal sac sur-
rounding a woven Dacron aortic graft. There was a tumorous mass
along the noncoronary cusp of the anastomosed site, with soft
granulation tissue in it (Figure 1). The tumor extended into the
aneurysmal sac and invaded the graft inside as well. The brain had
multiple metastatic tumors and expanding hemorrhaging. There
were no metastatic tumors in the other organs.
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doi:10.1016/j.jtcvs.2004.01.021Microscopic examination revealed a moderately differentiated
angiosarcoma arranged in complex anastomosing channels and
irregular sheets (Figure 2).
Neoplastic endothelial cells proliferated on the Dacron graft,
mainly outside but also inside. Neoplasmic cells were also ob-
served among individual Dacron fibers. There were poorly cohe-
sive neoplasmatic cells in the wrap inclusion of the aneurysmal
sac. Among immunohistochemical markers for endothelial differ-
entiation, only CD31 was positive; CD34 and factor VIII were
both negative.
Discussion
Foreign bodies have been shown to induce sarcomas in experi-
mental animals,1 but it has only rarely been reported in human
subjects that sarcomas have developed adjacent to foreign material
introduced into the body either iatrogenically or accidentally.2 In
thoracic surgery various forms of Dacron prostheses are com-
monly used. Oppenheimer and colleagues1 briefly mentioned that
the common denomination of tumor-producing materials was a
long-chain polymer structure, such as Dacron. Seven sarcomas
have been reported arising in association with Dacron vascular
prostheses in the English-language literature.3-6 The present case is
angiosarcoma arising from the anastomosed site of the aortic root
with a Dacron aortic graft. Neoplastic cells strongly expressed
CD31, a reliable marker that has both relative specificity and
excellent sensitivity to angiosarcomas of all types,7,8 confirming
the pathologic diagnosis. Neoplastic cells infiltrated both sides of
the endothelial layer of the graft from the anastomosed site. There-
fore we speculate that the anastomosed site with a Dacron graft is
the origin of the angiosarcoma. Angiosarcoma has also been re-
ported to have developed at the site of defunctionalized arterio-
venous fistulas.9,10 The wrap inclusion of the aneurysmal sac
around the aortic root is one example of a defunctionalized arte-
riovenous fistula. There was a thrombus with neoplastic cells in it.
An exuberant host response around the foreign material might
represent an important intermediate step in the development of the
sarcoma.11 The cells in the inflammatory or repair process rarely
undergo a malignant transformation, which is probably associated
with an oncogene activation and a tumor suppressor gene inacti-
and Cardiovascular Surgery ● Volume 127, Number 6 1843
